Position in GRAL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$51
-$34 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Anfield Capital Management, LLC holds $198,399 across 7 Diagnostics & Research names. GRAL ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
249 | $122,390 | |
| 2 | DHR |
Danaher Corp /De/
|
322 | $61,051 | |
| 3 | DGX |
Quest Diagnostics Inc
|
40 | $7,839 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
11 | $5,282 | |
| 5 | ILMN |
Illumina, Inc.
|
8 | $986 | |
| 6 | LH |
Labcorp Holdings Inc.
|
3 | $800 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
1 | $51 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $51 | 1 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $85 | 1 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $59 | 1 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $51 | 1 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $25 | 1 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17 | 1 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $13 | 1 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $15 | 1 | Shares | Defined | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||